Mereo BioPharma Group plc Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$0.01 | -$0.01 | -$0.01 |
| Q2 2024 | 1 | -$0.01 | -$0.01 | -$0.01 |
| Q3 2024 | 4 | -$0.01 | $0.05 | $0.01 |
| Q1 2025 | 4 | -$0.00 | -$0.00 | -$0.00 |
| Q2 2025 | 2 | -$0.00 | -$0.00 | -$0.00 |
| Q3 2025 | 2 | -$0.01 | -$0.01 | -$0.01 |
| Q4 2025 | 2 | -$0.01 | -$0.01 | -$0.01 |
Mereo BioPharma Group plc Earnings Date And Information
Mereo BioPharma Group plc last posted its earnings results on Tuesday, November 12th, 2024. The company reported $-7.69 earnings per share for the quarter, missing analysts' consensus estimates of $-1.36 by $6.33. The company had revenue of 0 for the quarter and had revenue of 10.00 M for the year. Mereo BioPharma Group plc has generated $0 earnings per share over the last year ($-0.0447 diluted earnings per share) and currently has a price-to-earnings ratio of -13.27. Mereo BioPharma Group plc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 26th, 2025 based on prior year's report dates.
Mereo BioPharma Group plc Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/12/2024 | Q3 2024 | -$1.36 | -$0.10 | 1.26 | $0 | $0 |
| 08/13/2024 | Q2 2024 | -$0.09 | $19.75 M | $0 | ||
| 05/15/2024 | Q1 2024 | -$0.01 | $0 | |||
| 03/27/2024 | Q4 2023 | -$0.02 | -$0.01 | 0.01 | $361,100 | |
| 09/29/2023 | Q3 2023 | -$0.01 | $533,429 | |||
| 09/07/2023 | Q2 2023 | -$0.02 | -$0.02 | -0 | $8.79 M | |
| 03/28/2023 | Q1 2023 | -$0.01 | $3.56 M | |||
| 03/28/2023 | Q4 2022 | -$0.03 | $832,010 | |||
| 09/29/2022 | Q3 2022 | -$0.02 | $674,990 | |||
| 03/31/2022 | Q2 2022 | -$0.04 | $3.27 M | $0 | ||
| 03/31/2022 | Q1 2022 | -$0.11 | $462,390 | |||
| 03/31/2022 | Q4 2021 | $0.01 | $0 | |||
| 09/29/2021 | Q3 2021 | $0.14 | $308,582 | |||
| 03/31/2021 | Q2 2021 | $0.17 | $50.64 M | |||
| 03/31/2021 | Q1 2021 | $0.01 | $25.13 M | |||
| 03/31/2021 | Q4 2020 | -$0.75 | $0 | |||
| 09/29/2020 | Q3 2020 | -$0.22 | $0 | |||
| 06/16/2020 | Q2 2020 | -$0.11 | $0 | |||
| 06/16/2020 | Q1 2020 | -$3.29 | $0 | |||
| 06/15/2020 | Q4 2019 | -$0.26 | -$1.21 | -0.95 | $0 |
Mereo BioPharma Group plc Earnings: Frequently Asked Questions
-
When is Mereo BioPharma Group plc's earnings date?
Mereo BioPharma Group plc has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 26th, 2025 based off last year's report dates.
-
How can I listen to Mereo BioPharma Group plc's earnings conference call?
The conference call for Mereo BioPharma Group plc's latest earnings report can be listened to online.
-
How can I read Mereo BioPharma Group plc's conference call transcript?
The conference call transcript for Mereo BioPharma Group plc's latest earnings report can be read online.
-
How much revenue does Mereo BioPharma Group plc generate each year?
Mereo BioPharma Group plc (:MREO) has a recorded annual revenue of $10.00 M.
-
How much profit does Mereo BioPharma Group plc generate each year?
Mereo BioPharma Group plc (:MREO) has a recorded net income of $10.00 M. Mereo BioPharma Group plc has generated $-0.0447 earnings per share over the last four quarters.
-
What is Mereo BioPharma Group plc's price-to-earnings ratio?
Mereo BioPharma Group plc (:MREO) has a price-to-earnings ratio of -13.27 and price/earnings-to-growth ratio is 1.59.
